Matrubials YCアプリケーション

Summer 2021Active

MatrubialsはSummer 2021バッチでHealthcare企業としてY Combinatorを卒業しました。以下：会社の事業内容、創業者、そして実際のYCフォームで質問ごとに再構築されたYCへの応募内容。

YCバッチ: Summer 2021
業界: HealthcareDrug Discovery and Delivery
チーム規模: 4
ステータス: Active
ローンチ済み: 2021

創業者

Bruce GermanFounder
Carlito LebrillaFounder
David MillsFounder

Matrubialsの事業内容

Matrubials is an anti-infectives company, focused on human milk peptides as therapeutics to address antimicrobial resistance and modern diseases. Currently the global rise in severe bacterial infections and the drying pipeline of effective treatments are burdensome for healthcare and economics. Sculpted by evolution, milk, first food for the newborn, provides an exemplary solution to address the nutritive and protective challenges an infant is faced with. The anti-pathogenic molecules from milk can be developed into therapeutics geared towards all-age diseases. Our first indication is bacterial vaginosis, a bacterial dysbiosis related inflammation that results in recurrent infections, disruption of homeostasis and long-term clinical complications in women of reproductive age, including but not limited to preterm births, fertility issues and increased rates of STDs. Our next inflection point is the evaluation of rapidly acting and selective candidate peptides in pre-clinical host impact and early safety studies, which can aid clinical and portfolio development towards topical applications.

MatrubialsのYCアプリケーション、再構築済み

Y Combinator 申請

Matrubials 様、Summer 2021 バッチ。公開データから回答された、実際のフォームの質問。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Matrubials

Describe what your company does in 50 characters or less.

Milk-inspired therapeutics for infectious diseases

What is your company going to make? Please describe your product and what it does or will do.

We are developing antimicrobial peptides derived from human milk to treat bacterial infections. Our lead program targets bacterial vaginosis, aiming to restore microbial balance and prevent recurrent infections and inflammation that affect women's reproductive health. These peptides act selectively to avoid disrupting beneficial bacteria and offer a novel treatment approach against antimicrobial resistance.

Where do you live now, and where would the company be based after YC?

We live and work in Davis, CA. After YC, the company will remain based here to leverage local research connections and our core scientific team.

Explain your decision regarding location.

Davis hosts our founders and is near key research institutions. Staying here maintains continuity in science and development and supports our focused approach on milk-based therapeutics.

フルアプリケーションで21件の追加回答

はフルバージョンにあります。無料アカウントを作成して、他のすべてのYCバッチの横にあるYCインサイトで開いてください。

申請内容全体を見る

よくある質問

Matrubialsの実際のYCアプリケーションですか？

いいえ。Y Combinatorは提出されたアプリケーションを非公開にしています。これは再構築されたものです。実際のYCフォームの質問に、Matrubialsの公開データ（ローンチノート、創業者経歴、製品説明）から回答しています。Matrubialsのような会社がYCにどのようにアピールするかを示しており、彼らが提出したテキストではありません。